Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a... see more

Bullboard (TSXV:NGEN)

View:
Post by ENEMENEMYNEMOon Apr 25, 2024 8:53pm

PR Firm

This reeks of desperation. Makes zero sense. If results are positive then it will sell itself. Maybe they are gearing up for a stock offering!
Post by deepoil0808on Apr 25, 2024 8:38pm

Sedar filings HINT at inconclusive evidence (more testing)?

I conducted a review of the insider buying from February 15th 2024 to date.   The date of February 15th is when there were leaks of one patient doing well, followed up later with free ...more  
Post by deepoil0808on Apr 09, 2024 11:38pm

UGLY chart speaks VOLUMES

I am thinking out loud.    If the treatment really worked we would have seen a soaring stock price as results are evident by staff, by doctors, by family members etc.... It would be tough ...more  
Post by deepoil0808on Mar 26, 2024 11:44am

Stock sharply down from $ 3.80/share (leaked results???)

Stock has dropped SHARPLY from $ 3.80 per share. Sadly, shareholders are always the last to know.   From reading the chart one would speculate that the trial results either are failing or ...more  
Comment by holliganzon Mar 22, 2024 9:43am

RE:Bought deal RAISES questions. Why now?

the insider your referring to that sold was a director exercising stock options that were expiring. They only had enough cash for this trial. If the trial is successful they have fast track ...more  
Post by deepoil0808on Mar 21, 2024 7:34pm

Bought deal RAISES questions. Why now?

Stock has plunged from +/- $ 3.80 to $ 2.48 today, a big drop. One insider sold +/- 30% of their holdings at $ 3 Market place published an article PROMOTING the company while a bought deal of $ 20 ...more  
Comment by Pandoraon Mar 20, 2024 8:17pm

RE:Article

It's over my head but would this "NerveGen" medicine have any value in combating "Peripheral Neuropathy"?
Post by snarkymavenon Mar 20, 2024 12:47pm

Article

https://themarketonline.ca/can-nervgen-keep-a-lid-on-explosive-news-2024-03-20/
Comment by snarkymavenon Mar 20, 2024 12:46pm

RE:Brian Bayley sold 100,000 shares at $ 3/share

There are insiders with  large positions of stock at $1 that has a vesting date which is around now.  If they do not sell their shares, they lose out.  All any insider knows is if they ...more  
Comment by snarkymavenon Mar 20, 2024 12:42pm

RE:RE:RE:RE:Brian Bayley sold 100,000 shares at $ 3/share

There are insiders with  large positions of stock at $1 that has a vesting date which is around now.  If they do not sell their shares, they lose out.  All any insider knows is if they ...more